Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00363272
Recruitment Status : Completed
First Posted : August 15, 2006
Last Update Posted : January 16, 2013
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2008
  Study Completion Date : No date given